Knowledge Hub · GABI Nova Radio-HPLC
Radio-TLC produces the single number — %RCP — that gates the patient injection. Radio-HPLC produces the same release decision PLUS the impurity profile. This page unpacks why continuous flow detection is the radiochemical-purity gold standard, how Eur.Ph. and USP <823> cite it, and what the 21 CFR Part 11 audit trail captures.
Why this matters
Continuous chromatogram
Radio-TLC produces a single number — %RCP — that gates the patient injection. Radio-HPLC produces the same release decision PLUS the impurity profile: free radionuclide peak, intended-product peak, every impurity peak with its retention time. Method development, stability work and impurity quantitation need the chromatogram, not just the number. For the daily release programme, radio-HPLC + radio-TLC together cover both the release gate and the impurity audit.
Based on: Eur.Ph. Radiopharmaceutical Preparations general monograph 0125; USP <823> — Positron Emission Tomography Drugs.
Read source ↗Probe-per-isotope
Different isotope energies optimise on different scintillators. Tc-99m (140 keV) optimises on a thin NaI(Tl) or plastic scintillator with collimation. F-18 / Ga-68 (511 keV annihilation) optimises on a thicker scintillator with absorbed-photon coincidence rejection. Lu-177 (113 / 208 keV doublet) sits between. A swap-in probe means the radiopharmacy buys one chassis and changes probes per programme. The HPLC tower, the software, the audit trail stay constant.
Based on: IAEA Quality Assurance for Radioactivity Measurement in Nuclear Medicine; EANM technologist guide on radio-HPLC QC.
Read source ↗UV + radioactivity overlay
A radio-HPLC release run reads the radioactivity channel (the radio-detector) overlaid on the UV / PDA channel (the standard HPLC detector). The UV trace confirms the chemistry — the cold peptide eluted at the expected retention time. The radio trace confirms the radioactivity sits on that peak — the labelling chemistry tied the radionuclide to the peptide. Both peaks coinciding is the release signature. Either alone is not.
Based on: EANM Technologist Guide — Radiopharmaceutical QC; Eur.Ph. PSMA-617 and DOTATATE monographs.
Read source ↗Lead-castle background
A radiopharmacy bench operates in a non-trivial background — the dose calibrator at one end, the labelling vial in the lead pot, the radio-TLC scanner next door. The flow cell sees that background unless it is locally shielded. A lead castle around the cell tunes the background down to where the limit-of-detection on the impurity peaks is set by counting statistics on the run, not by the room background. Configuration is a site-PQ exercise; once tuned, it stays tuned.
Based on: IAEA TRS 466 — Quality Assurance for PET and PET/CT Systems; AAPM TG-211 PET-NM QA.
Read source ↗GMP + 21 CFR Part 11
AERB inspection of a hot-lab radiopharmacy reads the chain: which method version was used, what threshold was applied, what the chromatogram showed, who signed the release. The 21 CFR Part 11 audit trail captures all four on every release — method version locked, electronic signature non-repudiable, override capture with reason, retention through the AERB record-keeping window. No parallel paper log to maintain or reconcile.
Based on: US FDA 21 CFR Part 11 — Electronic Records, Electronic Signatures; AERB Safety Code for Nuclear Medicine Facility.
Read source ↗Pairs with radio-TLC + γ-spectrometry
A theranostic-era radiopharmacy runs three release checks on a Lu-177 batch: radio-TLC %RCP (binding chemistry), radio-HPLC chromatogram (impurity audit), gamma spectrometry (nuclide identity). The three live on three instruments but on one batch record. The radio-HPLC sits between the rapid release gate (TLC) and the identity gate (γ-spec) — slower than TLC, deeper than γ-spec on the impurity question.
Based on: IAEA Operational Guidance on Hospital Radiopharmacy; EANM PRRT practice guideline.
Read source ↗Pharmacopeial, IAEA and EANM documents that anchor the radio-HPLC release workflow.
US Pharmacopeia general chapter defining radiochemical-purity test methods and per-monograph release thresholds — radio-HPLC is the cited method for several PET radiopharmaceuticals.
European Pharmacopoeia general + per-isotope monographs that frame the radio-HPLC release method.
IAEA framework for PET radiopharmacy QC including instrument validation and background-management expectations.
EANM technologist-facing guide covering radio-HPLC chromatogram interpretation and per-isotope QC methods.
Where next